About Cardinal Health (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Industry, Sector and Symbol
Industry MED PRODS
Sub-IndustryHealth Care Distributors
Trailing P/E Ratio10.7321739130435
Forward P/E Ratio11.39
Sales & Book Value
Annual Sales$129.98 billion
Price / Sales0.15
Cash Flow$7.27 per share
Price / Cash8.49
Book Value$21.62 per share
Price / Book2.85
Net Income$1.29 billion
Return on Equity24.81%
Return on Assets4.34%
Cardinal Health (NYSE:CAH) Frequently Asked Questions
What is Cardinal Health's stock symbol?
Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."
How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?
Cardinal Health announced a quarterly dividend on Wednesday, February 7th. Stockholders of record on Monday, April 2nd will be given a dividend of $0.4624 per share on Sunday, April 15th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 3.00%. The ex-dividend date is Thursday, March 29th. View Cardinal Health's Dividend History.
How will Cardinal Health's stock buyback program work?
Cardinal Health announced that its Board of Directors has authorized a stock repurchase program on Thursday, February 8th 2018, which allows the company to repurchase $1,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's leadership believes its shares are undervalued.
How were Cardinal Health's earnings last quarter?
Cardinal Health Inc (NYSE:CAH) announced its earnings results on Thursday, February, 8th. The company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.14 by $0.17. The company had revenue of $35.19 billion for the quarter, compared to analyst estimates of $34.63 billion. Cardinal Health had a return on equity of 24.81% and a net margin of 1.37%. Cardinal Health's quarterly revenue was up 6.1% on a year-over-year basis. During the same period last year, the business earned $1.34 earnings per share. View Cardinal Health's Earnings History.
When will Cardinal Health make its next earnings announcement?
What guidance has Cardinal Health issued on next quarter's earnings?
Cardinal Health issued an update on its FY18 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of $5.25-$5.50 for the period, compared to the Thomson Reuters consensus estimate of $5.16.
Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2018?
16 Wall Street analysts have issued 12 month price objectives for Cardinal Health's stock. Their forecasts range from $64.00 to $83.00. On average, they anticipate Cardinal Health's stock price to reach $73.55 in the next year. View Analyst Ratings for Cardinal Health.
Are investors shorting Cardinal Health?
Cardinal Health saw a increase in short interest in February. As of February 15th, there was short interest totalling 14,114,454 shares, an increase of 49.6% from the January 31st total of 9,434,956 shares. Based on an average daily volume of 3,802,756 shares, the days-to-cover ratio is currently 3.7 days. Currently, 4.5% of the company's shares are sold short.
Who are some of Cardinal Health's key competitors?
Some companies that are related to Cardinal Health include Boston Scientific (BSX), Baxter International (BAX), Fresenius Medical Care AG & Co. (FMS), Essilor International (ESLOY), McKesson (MCK), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Sunny Optical Tech (SNPTF), Align Technology (ALGN), AmerisourceBergen (ABC), Lonza Group (LZAGY), IDEXX Laboratories (IDXX), Laboratory Corp. of America (LH), Smith & Nephew (SNN), Coloplast A/S (CLPBY), ResMed (RMD), Olympus (OCPNY) and ABIOMED (ABMD).
Who are Cardinal Health's key executives?
Cardinal Health's management team includes the folowing people:
- George S. Barrett, Executive Chairman of the Board (Age 62)
- Michael C. Kaufmann, Chief Executive Officer, Director (Age 55)
- Jorge Gomez, Chief Financial Officer (Age 50)
- Jon L. Giacomin, Chief Executive Officer—Medical Segment (Age 52)
- Pamela O. Kimmet, Chief Human Resource Officer (Age 59)
- Patricia B. Morrison, Executive Vice President - Customer Support Services and Chief Information Officer (Age 58)
- Michele A. M. Holcomb, Executive Vice President, Strategy and Corporate Development (Age 49)
- Craig S. Morford, Chief Legal and Compliance Officer (Age 58)
- David John Anderson, Independent Director (Age 68)
- Colleen F. Arnold, Independent Director (Age 60)
Has Cardinal Health been receiving favorable news coverage?
News stories about CAH stock have trended somewhat positive on Friday, according to Accern Sentiment. Accern scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardinal Health earned a news impact score of 0.15 on Accern's scale. They also gave press coverage about the company an impact score of 45.79 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
Who are Cardinal Health's major shareholders?
Cardinal Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.90%), Barrow Hanley Mewhinney & Strauss LLC (5.68%), Macquarie Group Ltd. (3.38%), American International Group Inc. (2.53%), Franklin Resources Inc. (2.00%) and Bank of New York Mellon Corp (1.60%). Company insiders that own Cardinal Health stock include Carole S Watkins, Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.
Which major investors are selling Cardinal Health stock?
CAH stock was sold by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Teacher Retirement System of Texas, CWM LLC, Franklin Resources Inc., Raymond James & Associates, Roystone Capital Management LP, Deutsche Bank AG and Alliancebernstein L.P.. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.
Which major investors are buying Cardinal Health stock?
CAH stock was acquired by a variety of institutional investors in the last quarter, including American International Group Inc., BlackRock Inc., Amundi Pioneer Asset Management Inc., Bank of New York Mellon Corp, Alps Advisors Inc., Element Capital Management LLC, Boston Partners and Brandes Investment Partners LP. View Insider Buying and Selling for Cardinal Health.
How do I buy shares of Cardinal Health?
Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardinal Health's stock price today?
One share of CAH stock can currently be purchased for approximately $61.71.
How big of a company is Cardinal Health?
Cardinal Health has a market capitalization of $20.67 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.75 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.
How can I contact Cardinal Health?
Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]
MarketBeat Community Rating for Cardinal Health (CAH)MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cardinal Health (NYSE:CAH) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Hold||Hold||Hold|
|Consensus Rating Score: ||2.00||2.13||2.20||2.23|
|Ratings Breakdown: ||2 Sell Rating(s)|
12 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
11 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
|1 Sell Rating(s)|
10 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
10 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$73.55||$74.80||$73.30||$76.78|
|Price Target Upside: ||19.18% upside||11.19% upside||24.45% upside||14.47% upside|
Cardinal Health (NYSE:CAH) Consensus Price Target History
Cardinal Health (NYSE:CAH) Analyst Ratings History
(Data available from 3/23/2016 forward)
Cardinal Health (NYSE:CAH) Earnings History and Estimates Chart
Cardinal Health (NYSE CAH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/8/2018||Q2 2018||$1.14||$1.31||$34.63 billion||$35.19 billion||View||N/A|
|11/6/2017||Q1 2018||$1.00||$1.09||$33.48 billion||$32.64 billion||View||N/A|
|8/2/2017||Q4 2017||$1.24||$1.31||$32.73 billion||$32.97 billion||View||Listen|
|5/1/2017||Q3 2017||$1.46||$1.53||$32.30 billion||$31.82 billion||View||Listen|
|2/7/2017||Q217||$1.23||$1.34||$33.63 billion||$33.10 billion||View||Listen|
|10/31/2016||Q117||$1.21||$1.24||$31.12 billion||$32.00 billion||View||Listen|
|8/2/2016||Q416||$1.13||$1.14||$31.06 billion||$31.40 billion||View||N/A|
|4/28/2016||Q316||$1.33||$1.43||$30.54 billion||$30.70 billion||View||Listen|
|2/1/2016||Q216||$1.26||$1.30||$29.23 billion||$31.40 billion||View||N/A|
|11/2/2015||Q116||$1.10||$1.38||$27.19 billion||$28.10 billion||View||N/A|
|7/30/2015||Q415||$0.99||$1.00||$26.05 billion||$27.50 billion||View||Listen|
|4/30/2015||Q3||$1.16||$1.19||$24.40 billion||$25.38 billion||View||N/A|
|1/29/2015||Q215||$1.11||$1.20||$23.43 billion||$25.50 billion||View||N/A|
|10/30/2014||Q115||$0.96||$1.00||$22.43 billion||$24.07 billion||View||N/A|
|8/4/2014||Q414||$0.81||$0.83||$21.88 billion||$2.90 billion||View||N/A|
|5/1/2014||Q314||$1.01||$1.01||$21.72 million||$21.40 million||View||N/A|
|1/31/2014||Q214||$0.84||$0.79||$20.74 billion||$22.20 billion||View||N/A|
|10/31/2013||Q114||$0.86||$1.10||$22.73 billion||$24.50 billion||View||N/A|
|8/1/2013||Q4 2013||$0.77||$0.79||$24.56 billion||$25.40 billion||View||N/A|
|5/2/2013||Q3 2013||$0.95||$1.20||$24.72 billion||$24.60 billion||View||N/A|
|2/5/2013||Q2 2013||$0.86||$0.93||$24.61 million||$22.75 million||View||N/A|
|10/30/2012||Q113||$0.79||$0.81||$26.33 million||$25.90 million||View||N/A|
Cardinal Health (NYSE:CAH) Earnings Estimates
2018 EPS Consensus Estimate: $5.10
2019 EPS Consensus Estimate: $6.51
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Cardinal Health (NYSE:CAH) Dividend Information
|Dividend Growth:||12.20% (3 Year Average)|
|Payout Ratio:||32.17% (Trailing 12 Months of Earnings) |
34.13% (Based on This Year's Estimates)
30.48% (Based on Next Year's Estimates)
|Track Record:||13 Years of Consecutive Dividend Growth|
Cardinal Health (NYSE:CAH) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Cardinal Health (NYSE CAH) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 89.98%
Cardinal Health (NYSE CAH) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/20/2018||Jon L Giacomin||CEO||Sell||7,995||$68.78||$549,896.10||63,043|| |
|2/14/2018||Patricia Morrison||Insider||Sell||28,532||$66.30||$1,891,671.60||36,157|| |
|1/22/2018||Michael C Kaufmann||CEO||Sell||18,586||$73.90||$1,373,505.40||211,849|| |
|5/12/2017||Jon L Giacomin||CEO of Cardinal Health's pharmaceutical segment||Sell||23,270||$72.87||$1,695,684.90||55,440|| |
|2/10/2017||George S Barrett||Chairman||Sell||217,994||$77.23||$16,835,676.62||682,225|| |
|11/10/2016||George S Barrett||Chairman||Sell||217,995||$71.29||$15,540,863.55||682,226|| |
|8/18/2016||Patricia Morrison||Insider||Sell||43,959||$82.50||$3,626,617.50||99,662|| |
|8/18/2016||Stuart G Laws||SVP||Sell||9,703||$82.45||$800,012.35||2,718|| |
|8/16/2016||Jon L Giacomin||CEO||Sell||47,251||$82.77||$3,910,965.27||44,598|| |
|8/11/2016||Craig S Morford||Insider||Sell||12,697||$83.13||$1,055,501.61||90,811|| |
|8/10/2016||Donald M Jr. Casey||CEO||Sell||59,180||$83.59||$4,946,856.20||164,803|| |
|8/10/2016||George S Barrett||Chairman||Sell||250,000||$83.63||$20,907,500.00||510,762|| |
|8/9/2016||George S Barrett||CEO||Sell||129,818||$83.76||$10,873,555.68||510,762|| |
|8/8/2016||George S Barrett||CEO||Sell||20,428||$83.75||$1,710,845.00||510,762|| |
|5/20/2016||Carole S Watkins||Insider||Sell||84,617||$77.33||$6,543,432.61||116,202|| |
|11/6/2015||Falk T. Stephen||EVP||Sell||30,085||$87.66||$2,637,251.10||33,633|| |
|8/20/2015||George S. Barrett||CEO||Sell||300,000||$83.08||$24,924,000.00||406,134|| |
|5/12/2015||Falk T Stephen||EVP||Sell||39,428||$86.12||$3,395,539.36|| |
|5/11/2015||George S Barrett||CEO||Sell||300,000||$86.44||$25,932,000.00|| |
|3/4/2015||Colleen F Arnold||Director||Sell||9,801||$87.65||$859,057.65|| |
|3/3/2015||Richard C Notebaert||Director||Sell||9,801||$88.20||$864,448.20|| |
|2/20/2015||Carole S Watkins||Insider||Sell||33,847||$87.00||$2,944,689.00|| |
|2/10/2015||Carole S Watkins||Insider||Sell||50,770||$85.00||$4,315,450.00|| |
|2/10/2015||George S Barrett||CEO||Sell||300,000||$84.87||$25,461,000.00|| |
|11/7/2014||Mark R Blake||EVP||Sell||24,668||$79.50||$1,961,106.00|| |
|9/5/2014||Carole S Watkins||Insider||Sell||40,794||$75.00||$3,059,550.00|| |
|9/4/2014||Michael C Kaufmann||CEO||Sell||50,216||$74.95||$3,763,689.20|| |
|8/27/2014||Jeffrey William Henderson||CFO||Sell||26,567||$72.63||$1,929,561.21|| |
|8/18/2014||Jeffrey William Henderson||CFO||Sell||78,637||$72.06||$5,666,582.22|| |
|8/18/2014||Mark R Blake||EVP||Sell||4,782||$72.15||$345,021.30|| |
|8/18/2014||Michael C Kaufmann||CEO||Sell||6,833||$72.06||$492,385.98|| |
|8/8/2014||Craig S Morford||Insider||Sell||43,359||$70.03||$3,036,430.77|| |
|8/8/2014||Jeffrey William Henderson||CFO||Sell||118,093||$69.72||$8,233,443.96|| |
|7/24/2014||Mark R Blake||EVP||Sell||23,114||$73.41||$1,696,798.74|| |
|7/24/2014||Stuart G Laws||CAO||Sell||21,266||$72.50||$1,541,785.00|| |
|7/14/2014||Jeffrey William Henderson||CFO||Sell||23,632||$70.65||$1,669,600.80|| |
|5/19/2014||Mark Blake||EVP||Sell||4,703||$66.50||$312,749.50||24,416|| |
|5/13/2014||Mark Blake||EVP||Sell||2,822||$66.50||$187,663.00||29,119|| |
|5/7/2014||Jeffrey William Henderson||CFO||Sell||27,031||$63.83||$1,725,388.73||107,096|| |
|2/11/2014||Mark Blake||EVP||Sell||2,330||$68.53||$159,674.90||31,941|| |
|2/11/2014||Michael Kaufmann||CEO||Sell||388,995||$67.46||$26,241,602.70||115,969|| |
|2/10/2014||George Barrett||CEO||Sell||200,000||$66.64||$13,328,000.00||334,102|| |
|2/5/2014||Gregory Kenny||Director||Sell||18,175||$65.39||$1,188,463.25||19,584|| |
|2/4/2014||Carole Watkins||Insider||Sell||46,666||$65.71||$3,066,422.86||53,544|| |
|2/4/2014||Falk Stephen||EVP||Sell||17,926||$65.56||$1,175,228.56||24,239|| |
|2/4/2014||Richard Notebaert||Director||Sell||10,727||$65.68||$704,549.36||33,750|| |
|11/11/2013||George Barrett||CEO||Sell||200,000||$62.71||$12,542,000.00||334,102|| |
|9/11/2013||Mark R Blake||EVP||Sell||14,584||$51.53||$751,513.52|| |
|8/19/2013||Mark Blake||EVP||Sell||4,925||$51.27||$252,504.75||30,641|| |
|8/16/2013||Falk Stephen||EVP||Sell||10,000||$51.50||$515,000.00||34,239|| |
|8/15/2013||Craig Morford||Insider||Sell||20,000||$51.33||$1,026,600.00||81,554|| |
|8/13/2013||George Barrett||CEO||Sell||75,000||$52.09||$3,906,750.00||325,787|| |
|8/13/2013||Jeffrey William Henderson||CFO||Sell||54,590||$51.99||$2,838,134.10||167,390|| |
|8/8/2013||Calvin Darden||Director||Sell||3,254||$51.48||$167,515.92||18,131|| |
|8/5/2013||Mark Blake||EVP||Sell||29,166||$51.53||$1,502,923.98||32,741|| |
|7/26/2013||Jeffrey William Henderson||CFO||Sell||76,781||$50.99||$3,915,063.19|| |
|7/18/2013||Jeffrey William Henderson||CFO||Sell||57,623||$49.99||$2,880,573.77|| |
|7/15/2013||Jeffrey William Henderson||CFO||Sell||14,660||$49.99||$732,853.40|| |
|7/11/2013||Jeffrey William Henderson||CFO||Sell||83,211||$48.99||$4,076,506.89|| |
|6/19/2013||John F Finn||Director||Sell||11,070||$48.51||$537,005.70|| |
|5/28/2013||Jean G Spaulding||Director||Sell||8,350||$47.35||$395,372.50|| |
|5/22/2013||Richard C Notebaert||Director||Sell||3,197||$48.10||$153,775.70|| |
|5/20/2013||Carole S Watkins||Insider||Sell||4,612||$48.00||$221,376.00|| |
|5/20/2013||Jean G Spaulding||Director||Sell||1,666||$47.90||$79,801.40|| |
|11/1/2012||Stuart G Laws||CAO||Sell||2,564||$41.22||$105,688.08|| |
|10/4/2012||Jeffrey William Henderson||CFO||Sell||46,226||$40.00||$1,849,040.00|| |
Cardinal Health (NYSE CAH) News Headlines
Cardinal Health (NYSE:CAH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cardinal Health (NYSE:CAH) Income Statement, Balance Sheet and Cash Flow Statement
Cardinal Health (NYSE CAH) Stock Chart for Friday, March, 23, 2018